OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023

Rhea-AI Summary

OrthoPediatrics Corp. (NASDAQ: KIDS) announced it will release its Q4 and full year 2022 financial results on February 28, 2023, after market close. A conference call to discuss these results is scheduled for March 1, 2023, at 8:00 a.m. ET. The call can be accessed through a live and archived webcast on the company's website. OrthoPediatrics specializes in pediatric orthopedics, offering 46 surgical systems for trauma, scoliosis, and sports medicine, distributing its products in the U.S. and over 70 countries globally.

Positive

• Company scheduled to release key financial results, potentially indicating growth potential.
• Wide product range with 46 surgical systems targeting significant pediatric orthopedic categories.

Negative

• None.

WARSAW, Ind., Feb. 14, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2022 financial results on Tuesday, February 28, 2023, after the market closes. OrthoPediatrics will host a conference call on Wednesday, March 1, 2023, at 8:00 a.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 46 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact:
Philip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

FAQ

When will OrthoPediatrics release its Q4 2022 financial results?

OrthoPediatrics will release its Q4 2022 financial results on February 28, 2023, after market close.

What time is OrthoPediatrics' conference call scheduled for?

The conference call is scheduled for March 1, 2023, at 8:00 a.m. ET.

How can I access the OrthoPediatrics conference call?

The conference call can be accessed via a live and archived webcast on the OrthoPediatrics website.

What is OrthoPediatrics known for?

OrthoPediatrics is known for advancing the field of pediatric orthopedics with a comprehensive product offering.

How many surgical systems does OrthoPediatrics market?

OrthoPediatrics markets 46 surgical systems in the pediatric orthopedic market.